Scott E. Plevy

Host Defense Mechanisms Triggered by Microbial Lipoproteins Through Toll-Like Receptors

Hans D. Brightbill, Daniel H. Libraty, Stephan R. Krutzik et al. · Science · 1999 · 1.7K citations

Life Sciences, Immunology, Microbiology +17

Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor–neutralizing therapy in patients with inflammatory bowel disease

Nathaniel R. West, Ahmed N. Hegazy, Benjamin M. J. Owens et al. · Nature Medicine · 2017 · 805 citations · Full text

Medicine, Immunology, Oncology +17

Infliximab Prevents Crohn's Disease Recurrence After Ileal Resection

Miguel Regueiro, Wolfgang H. Schraut, Leonard Baidoo et al. · Gastroenterology · 2008 · 602 citations

Medicine, Clinical Sciences, Immunology +16

The Incidence and Management of Infusion Reactions To Infliximab: A Large Center Experience

Adam S. Cheifetz, Michelle V. Smedley, S Bogetz Martin et al. · The American Journal of Gastroenterology · 2003 · 489 citations

Life Sciences, Immunology, Pharmacotherapy +14

Whole-Virome Analysis Sheds Light on Viral Dark Matter in Inflammatory Bowel Disease

Adam G. Clooney, Thomas Sutton, Andrey N. Shkoporov et al. · Cell Host & Microbe · 2019 · 481 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +16